Stroke Trial, Recruiting NCT06904768 Sponsor: Arnaoutis Stylianos Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06904768
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been clinically diagnosed with a stroke and are within 6 months of it happening
  • People who have weakness or paralysis affecting one arm as a result of their stroke
  • People whose affected arm has limited movement, at a level below stage 4 on a scale doctors use to measure stroke recovery (called the Brunnstrom scale) (confirm with trial site)
  • People who are able to walk with some level of independence, scoring above 3 on a walking ability scale called the Functional Ambulation Category
  • People aged between 40 and 80 years old
  • People who are able to understand and follow simple instructions
  • People who are well enough physically to take part in balance and movement testing
  • People who have given their written agreement to take part in the trial

Who may not be able to join:

  • People with severe problems with memory or thinking, such as scoring below 23 on a standard cognitive test called the MMSE
  • People with vision problems or inner ear problems that affect their balance
  • People with significant problems affecting the bones, joints, or muscles of their legs
  • People with heart or lung conditions that are not well controlled
  • People who use mobility or support equipment that would prevent a shoulder sling from being worn
  • People with severe difficulties with speaking or understanding language that would make communication during the trial too difficult
  • People who have skin wounds or injuries on or around the shoulder area that would prevent a sling from being used

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nikolaos Chrysagis, University of West Attica

Phone: +306981199528

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Arnaoutis Stylianos
Registry
ClinicalTrials.gov
Start date
13 March 2025
Est. completion
1 April 2025

Where this trial is recruiting

🇬🇷 Greece

Primary endpoints

Timed Up and Go (TUG) Test; Functional Reach Test (FRT); Modified Four Square Step Test (mFSST)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov